Evaluation of salivary procalcitonin levels in different periodontal diseases

Journal of Periodontology

Volumn 86, Issue 6, 2015, Pages 820-826

  Hendek, Meltem Karsiyaka ^a   Erdemir, Ebru Olgun ^a   Kisa, Ucler ^b  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

Diagnosis; Gingivitis; Periodontitis; Procalcitonin; Saliva

Indexed keywords

BIOLOGICAL MARKER; CALCITONIN; GLYCOPROTEIN; PROTEIN PRECURSOR; SALIVA PROTEIN;

ADULT; AGGRESSIVE PERIODONTITIS; CHRONIC PERIODONTITIS; CLASSIFICATION; FEMALE; GINGIVITIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PERIODONTAL DISEASE; PERIODONTAL INDEX; PERIODONTAL POCKET; PLAQUE INDEX; YOUNG ADULT;

ADULT; AGGRESSIVE PERIODONTITIS; BIOMARKERS; CALCITONIN; CHRONIC PERIODONTITIS; DENTAL PLAQUE INDEX; FEMALE; GINGIVITIS; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL DISEASES; PERIODONTAL INDEX; PERIODONTAL POCKET; PROTEIN PRECURSORS; SALIVARY PROTEINS AND PEPTIDES; YOUNG ADULT;

EID: 84930410742     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2015.130751     Document Type: Article

References (49)

1. Cekici A, Kantarci A, Hasturk H, Van Dyke TE. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000 2014;64:57-80.
2. Wilson M, Reddi K, Henderson B. Cytokine-inducing components of periodontopathogenic bacteria. J Periodontal Res 1996;31:393-407.
3. Kinney JS, Morelli T, Oh M, et al. Crevicular fluid biomarkers and periodontal disease progression. J Clin Periodontol 2014;41:113-120.
4. Iannitti T, Rottigni V, Palmieri B. Role of free radicals and antioxidant defences in oral cavity-related pathologies. J Oral Pathol Med 2012;41:649-661.
5. Lee YH, Wong DT. Saliva: An emerging biofluid for early detection of diseases. Am J Dent 2009;22:241-248.
6. Li Y, Denny P, Ho CM, et al. The Oral Fluid MEMS/NEMS Chip (OFMNC): Diagnostic and translational applications. Adv Dent Res 2005;18:3-5.
7. Aguirre A, Testa-Weintraub LA, Banderas JA, Haraszthy GG, Reddy MS, Levine MJ. Sialochemistry: A diagnostic tool? Crit Rev Oral Biol Med 1993;4:343-350.
8. Kaufman E, Lamster IB. Analysis of saliva for periodontal diagnosis - A review. J Clin Periodontol 2000;27:453-465.
9. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-518.
10. Müller B, White JC, Nylén ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001;86:396-404.
11. Balog A, Ocsovszki I, Mándi Y. Flow cytometric analysis of procalcitonin expression in human monocytes and granulocytes. Immunol Lett 2002;84:199-203.
12. Carrol ED, Thomson AP, Hart CA. Procalcitonin as a marker of sepsis. Int J Antimicrob Agents 2002;20:1-9.
13. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis. Clin Infect Dis 2004;39:206-217.
14. Liu YC, Lerner UH, Teng YT. Cytokine responses against periodontal infection: Protective and destructive roles. Periodontol 2000 2010;52:163-206.
15. Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: Assembling the players. Periodontol 2000 1997;14:33-53.
16. Offenbacher S, Barros S, Mendoza L, et al. Changes in gingival crevicular fluid inflammatory mediator levels during the induction and resolution of experimental gingivitis in humans. J Clin Periodontol 2010;37:324-333.
17. Trombelli L, Scapoli C, Carrieri A, Giovannini G, Calura G, Farina R. Interleukin-1 beta levels in gingival crevicular fluid and serum under naturally occurring and experimentally induced gingivitis. J Clin Periodontol 2010;37:697-704.
18. Kinney JS, Ramseier CA, Giannobile WV. Oral fluid-based biomarkers of alveolar bone loss in periodontitis. Ann N Y Acad Sci 2007;1098:230-251.
19. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
20. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
21. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21:533-551.
22. Edgar WM. Saliva: Its secretion, composition and functions. Br Dent J 1992;172:305-312.
23. Hu S, Arellano M, Boontheung P, et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 2008;14:6246-6252.
24. Li Y, St John MA, Zhou X, et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 2004;10:8442-8450.
25. Hu S, Wang J, Meijer J, et al. Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum 2007;56:3588-3600.
26. Salminen A, Gursoy UK, Paju S, et al. Salivary biomarkers of bacterial burden, inflammatory response, and tissue destruction in periodontitis. J Clin Periodontol 2014;41:442-450.
27. Rathnayake N, Akerman S, Klinge B, et al. Salivary biomarkers of oral health: A cross-sectional study. J Clin Periodontol 2013;40:140-147.
28. Ramseier CA, Kinney JS, Herr AE, et al. Identification of pathogen and host-response markers correlated with periodontal disease. J Periodontol 2009;80:436-446.
29. Kinney JS, Morelli T, Braun T, et al. Saliva/pathogen biomarker signatures and periodontal disease progression. J Dent Res 2011;90:752-758.
30. Giannobile WV, Beikler T, Kinney JS, Ramseier CA, Morelli T, Wong DT. Saliva as a diagnostic tool for periodontal disease: Current state and future directions. Periodontol 2000 2009;50:52-64.
31. Bratthall D, Hänsel Petersson G. Cariogram - A multifactorial risk assessment model for a multifactorial disease. Community Dent Oral Epidemiol 2005;33:256-264.
32. Christodoulides N, Floriano PN, Miller CS, et al. Labon-a-chip methods for point-of-care measurements of salivary biomarkers of periodontitis. Ann N Y Acad Sci 2007;1098:411-428.
33. Streckfus C, Bigler L, Dellinger T, Dai X, Kingman A, Thigpen JT. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: A preliminary study. Clin Cancer Res 2000;6:2363-2370.
34. Hu S, Zhou M, Jiang J, et al. Systems biology analysis of Sjögren's syndrome and mucosa-associated lymphoid tissue lymphoma in parotid glands. Arthritis Rheum 2009;60:81-92.
35. Yaari A, Tovbin D, Zlotnick M, et al. Detection of HCV salivary antibodies by a simple and rapid test. J Virol Methods 2006;133:1-5.
36. Ugarte H, Silva E, Mercan D, De Mendoncxa A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999;27:498-504.
37. Müller B, Becker KL, Schächinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000;28:977-983.
38. Ziebolz D, Jäger GC, Hornecker E, Mausberg RF. Periodontal findings and blood analysis of blood donors: A pilot study. J Contemp Dent Pract 2007;8:43-50.
39. Bassim CW, Redman RS, DeNucci DJ, Becker KL, Nylen ES. Salivary procalcitonin and periodontitis in diabetes. J Dent Res 2008;87:630-634.
40. Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994;79:1605-1608.
41. Preas HL 2nd, Nylen ES, Snider RH, et al. Effects of anti-inflammatory agents on serum levels of calcitonin precursors during human experimental endotoxemia. J Infect Dis 2001;184:373-376.
42. D'Aiuto F, Parkar M, Andreou G, et al. Periodontitis and systemic inflammation: Control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 2004;83:156-160.
43. Armitage GC. Comparison of the microbiological features of chronic and aggressive periodontitis. Periodontol 2000 2010;53:70-88.
44. Wiedermann FJ, Kaneider N, Egger P, et al. Migration of human monocytes in response to procalcitonin. Crit Care Med 2002;30:1112-1117.
45. Polson AM, Goodson JM. Periodontal diagnosis. Current status and future needs. J Periodontol 1985;56:25-34.
46. Griffiths GS, Smart GJ, Bulman JS, Weiss G, Shrowder J, Newman HN. Comparison of clinical outcomes following treatment of chronic adult periodontitis with subgingival scaling or subgingival scaling plus metronidazole gel. J Clin Periodontol 2000;27:910-917.
47. Greenstein G. Periodontal diseases are curable. J Periodontol 2002;73:950-953.
48. Garlet GP. Destructive and protective roles of cytokines in periodontitis: A re-appraisal from host defense and tissue destruction viewpoints. J Dent Res 2010;89:1349-1363.
49. Graves DT, Fine D, Teng YT, Van Dyke TE, Hajishengallis G. The use of rodent models to investigate hostbacteria interactions related to periodontal diseases. J Clin Periodontol 2008;35:89-105.